Details
Oncology patients are heavily impacted by the ongoing SARS-CoV-2 pandemic. Illumina invites you to a virtual discussion on the topics below with a panel of experts on Wednesday, December 2, 11 am PST.
- How the pandemic caused delays in screening and diagnosis of new cancer patients.
- The impact of delayed cancer testing and late stage diagnosis.
- Review survey results on the value of Comprehensive Genomic Panel at initial diagnosis and Comprehensive Genomic Profiling (CGP)versus iterative testing during a pandemic.
- The impact of shortened turn-around-time for onsite CGP testing vs send out.
- Using liquid biopsy to detect actionable variants.
- How liquid biopsy can alleviate the need for tissue biopsy and hospital visits.
Panelists:
Phil Febbo, MD, PhD
Chief Medical Officer
Illumina
David Eberhard, MD, PhD
Senior Medical Director of Oncology
Illumina
Dr. Christopher Lum, MD
Medical Director
Queens Medical Center
Dr. Peter Vu, MD, MS
Assistant Clinical Professor of Medicine
UC San Diego, Division of Hematology and Oncology
Fill Out Form to Access Webinar
Your email address is never shared with third parties.
- Date & Time
- Dec 2, 2020
- 11:00 AM (PST)
- Topic
- Oncology